A patient with stage 3 chronic kidney disease and hypertension has been started on a calcium channel blocker to manage elevated blood pressure. Which of the following nursing interventions is most important to monitor the effectiveness of this treatment?

C) Check the patient's blood pressure and heart rate routinely.

A) Monitor the patient's blood glucose levels regularly.

B) Assess for signs of peripheral edema regularly.

C) Check the patient's blood pressure and heart rate routinely.

D) Evaluate the patient's dietary sodium intake.

A patient with hypertension and newly diagnosed stage 3 chronic kidney disease has been found to have mild left ventricular hypertrophy and dyslipidemia. Which nursing intervention is most appropriate to address the patient's current condition and prevent further complications?

B) Educate the patient on the importance of adhering to a low-sodium, heart-healthy diet.

A) Encourage the patient to increase sodium intake to support renal function.

B) Educate the patient on the importance of adhering to a low-sodium, heart-healthy diet.

C) Advise the patient to limit fluid intake to prevent fluid overload.

D) Recommend the patient to engage in high-intensity interval training to promote cardiovascular health.

A patient receiving treatment for hypertension is experiencing dizziness upon standing and mild peripheral edema. What is the most appropriate nursing intervention to address these symptoms?

A) Instruct the patient to rise slowly from sitting or lying positions and monitor blood pressure regularly.

B) Encourage the patient to increase fluid intake to counteract the effects of antihypertensive medications.

C) Advise the patient to stop taking the prescribed calcium channel blocker immediately.

D) Suggest reducing sodium intake further to manage the peripheral edema.

A patient recently started on a new antihypertensive regimen presents with episodes of dizziness upon standing and mild peripheral edema. Blood pressure drops from 130/85 mmHg when seated to 110/70 mmHg when standing. Which nursing intervention should be prioritized to address the patient's current symptoms?

B) Educate the patient on rising slowly from a seated or lying position to prevent dizziness.

A) Instruct the patient to increase dietary sodium intake to manage the dizziness.

B) Educate the patient on rising slowly from a seated or lying position to prevent dizziness.

C) Advise the patient to discontinue the antihypertensive medication until symptoms resolve.

D) Recommend the patient limit fluid intake to reduce peripheral edema.

A patient with newly diagnosed heart failure with preserved ejection fraction (HFpEF) is started on a low-dose loop diuretic to manage peripheral edema. Which nursing intervention is most important to implement to ensure the safety and effectiveness of this treatment?

C) Assess the patient's weight daily and monitor for sudden changes.

A) Monitor blood pressure and heart rate before and after administration of the diuretic.

B) Educate the patient on the importance of dietary potassium intake to prevent hypokalemia.

C) Assess the patient's weight daily and monitor for sudden changes.

D) Encourage the patient to increase fluid intake to prevent dehydration.

A patient with a history of hypertension and dyslipidemia presents with peripheral edema and is found to have mild left ventricular hypertrophy and a reduced ejection fraction. After initiating a low-dose loop diuretic, which of the following assessments is most critical for the nurse to perform to ensure the safe management of this patient's condition?

B) Assess for muscle weakness and cramps

A) Monitor blood glucose levels

B) Assess for muscle weakness and cramps

C) Evaluate for signs of digoxin toxicity

D) Check for signs of pulmonary embolism

A patient with a history of cardiovascular issues is receiving a loop diuretic and presents with increased serum creatinine and decreased potassium levels. The healthcare team decides to adjust the medication regimen. What is the most appropriate nursing action to prioritize in this situation?

C) Initiate a potassium-sparing diuretic and closely monitor renal function and electrolyte levels.

A) Administer the loop diuretic as prescribed and monitor for changes in blood pressure.

B) Educate the patient on increasing dietary potassium intake and arrange for a follow-up appointment.

C) Initiate a potassium-sparing diuretic and closely monitor renal function and electrolyte levels.

D) Increase the frequency of vital sign monitoring to detect early signs of hypotension.

A nurse is reviewing the laboratory results of a patient who has been started on a loop diuretic. The results show an increase in serum creatinine from 1.0 mg/dL to 1.5 mg/dL, BUN of 25 mg/dL, and a potassium level of 3.2 mEq/L. The patient's blood pressure is stable at 120/78 mmHg, and peripheral edema has decreased. Which intervention should the nurse anticipate based on these findings?

B) Add a potassium-sparing diuretic to the medication regimen.

A) Increase the dose of the loop diuretic to further reduce edema.

B) Add a potassium-sparing diuretic to the medication regimen.

C) Discontinue all diuretics to prevent further renal impairment.

D) Administer intravenous potassium supplements immediately.

A patient with a history of hypertension and renal insufficiency is being monitored for fluid overload and electrolyte imbalance after a recent medication adjustment. Her serum potassium is 3.8 mEq/L, serum creatinine is 1.6 mg/dL, and BUN is 28 mg/dL. She reports increased fatigue, and physical examination reveals mild jugular venous distention and crackles at the lung bases. Which nursing intervention is most appropriate to address her current clinical status?

C) Monitor the patient's daily weight and fluid intake/output to assess fluid balance.

A) Increase the dose of the potassium-sparing diuretic to enhance diuresis.

B) Educate the patient on the importance of a low-protein diet to reduce renal workload.

C) Monitor the patient's daily weight and fluid intake/output to assess fluid balance.

D) Discontinue the loop diuretic immediately to prevent further renal impairment.

A patient with a recent adjustment in her medication regimen, including a potassium-sparing diuretic, presents with improved serum potassium levels but increased serum creatinine and BUN. She reports fatigue, and a physical exam reveals mild jugular venous distention and crackles at the lung bases. What is the priority nursing intervention to address these findings?

C) Consult with the healthcare provider to evaluate potential adjustment of the diuretic therapy.

A) Increase the dosage of the potassium-sparing diuretic to further improve potassium levels.

B) Educate the patient on reducing fluid intake to manage fluid overload symptoms.

C) Consult with the healthcare provider to evaluate potential adjustment of the diuretic therapy.

D) Encourage the patient to engage in more physical activity to alleviate fatigue.

hypertension - Nursing Case Study

Pathophysiology

• Primary mechanism: Increased systemic vascular resistance due to arterial narrowing or stiffness elevates blood pressure. This is often caused by factors like arteriosclerosis, where plaque buildup in arteries reduces their elasticity and diameter, requiring the heart to pump harder to circulate blood.

• Secondary mechanism: Overactivity of the renin-angiotensin-aldosterone system (RAAS) leads to increased blood volume and vascular resistance. Angiotensin II constricts blood vessels, while aldosterone promotes sodium and water retention, contributing to higher blood pressure.

• Key complication: Persistent hypertension can damage organs such as the heart, kidneys, and brain, leading to conditions like heart failure, renal failure, and stroke due to the sustained high pressure and strain on blood vessels.

Patient Profile

Demographics:

52-year-old female, office administrator

History:

• Key past medical history: Diagnosed with hypertension 5 years ago, borderline type 2 diabetes, family history of cardiovascular disease

• Current medications: Lisinopril 20 mg daily, Metformin 500 mg twice daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent headache and dizziness

• Key symptoms: Fatigue, occasional blurred vision, mild swelling in ankles

• Vital signs: Blood pressure 160/100 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F

Section 1

New Diagnostic Results:

Following the initial assessment, the healthcare team decided to conduct further diagnostic tests to evaluate the extent of the patient's hypertension-related complications and to adjust her treatment plan accordingly. A comprehensive metabolic panel revealed mild renal impairment, with a serum creatinine level of 1.6 mg/dL (normal range: 0.6-1.2 mg/dL) and a glomerular filtration rate (GFR) of 55 mL/min/1.73 m², indicating stage 3 chronic kidney disease. Additionally, a lipid profile showed elevated LDL cholesterol at 160 mg/dL (optimal: <100 mg/dL) and a decreased HDL cholesterol level at 38 mg/dL (optimal: ≥60 mg/dL), highlighting an increased risk for cardiovascular events.

An echocardiogram was also performed, revealing mild left ventricular hypertrophy, a common consequence of prolonged hypertension. This finding suggests that the patient's heart is beginning to adapt to the increased workload caused by sustained high blood pressure. Despite the enlargement, there was no evidence of heart failure at this stage. However, the presence of left ventricular hypertrophy emphasizes the need for more aggressive blood pressure management to prevent progression to more severe cardiac complications.

These diagnostic results underscore the importance of addressing both the hypertension and associated risks, such as renal impairment and dyslipidemia, to prevent further damage. The healthcare team is considering intensifying antihypertensive therapy, potentially adding a calcium channel blocker to the regimen, and initiating lifestyle modifications focusing on diet and exercise. These steps aim to manage her blood pressure more effectively, reduce cardiovascular risk, and slow the progression of renal disease. The team will continue to monitor the patient closely, adjusting treatment as needed to achieve optimal outcomes and prevent further complications.

Section 2

As the medical team implements the new treatment plan, they closely monitor the patient's response to the adjusted antihypertensive therapy and lifestyle modifications. Initially, the patient shows some improvement in blood pressure control, with readings averaging around 130/85 mmHg, down from her previous baseline of 150/95 mmHg. However, during a follow-up visit, the patient reports experiencing episodes of dizziness, particularly upon standing, suggesting the possibility of orthostatic hypotension. Upon examination, her blood pressure drops to 110/70 mmHg when moving from a seated to a standing position, confirming the suspicions. This side effect prompts the healthcare team to evaluate the current medication dosages and consider adjusting the regimen to balance optimal blood pressure control with minimizing adverse effects.

Concurrently, repeat laboratory tests indicate that the patient's renal function has not significantly worsened, with serum creatinine stabilizing at 1.5 mg/dL and GFR at 58 mL/min/1.73 m². While this is reassuring, it remains imperative to further address her dyslipidemia. The team prescribes a statin to lower her LDL cholesterol and potentially improve her HDL levels, aiming to reduce her cardiovascular risk. Furthermore, the patient is encouraged to adhere strictly to dietary recommendations, particularly the DASH diet, which is designed to aid in managing hypertension and improving lipid profiles.

Despite these interventions, a new complication arises. The patient begins to experience mild peripheral edema, particularly in the lower extremities. This development could be attributed to the addition of the calcium channel blocker or could indicate early signs of fluid retention related to heart function. An assessment of her heart sounds reveals no murmurs, but a slight S4 gallop is detected, indicating increased stiffness of the left ventricle. The team decides to monitor her closely, potentially incorporating diuretics into her treatment if the edema persists or worsens. This highlights the intricacies of managing a complex case where multiple comorbidities interact, requiring ongoing clinical reasoning and adjustments to the therapeutic approach to achieve the best patient outcomes.

Section 3

In the weeks following the addition of the statin and the onset of peripheral edema, the healthcare team decides to conduct a detailed cardiac evaluation and additional laboratory tests to further elucidate the patient's status. An echocardiogram is performed, revealing mild left ventricular hypertrophy and a slightly reduced ejection fraction of 50%, suggesting potential early signs of heart failure with preserved ejection fraction (HFpEF). This finding aligns with the detection of the S4 gallop, indicating diastolic dysfunction. Given these results, the team is prompted to consider the need for a more aggressive heart failure management plan while continuing to address her hypertension and dyslipidemia.

Meanwhile, the patient's peripheral edema persists despite adherence to dietary sodium restrictions. In light of the echocardiographic findings and in an effort to mitigate fluid retention, the medical team decides to initiate a low-dose loop diuretic. This intervention aims to alleviate the edema while monitoring her electrolytes closely to avoid hypokalemia or other imbalances. Over the next few follow-up visits, the patient's edema shows slight improvement, and her blood pressure stabilizes around 125/80 mmHg, with no further episodes of orthostatic hypotension reported.

These developments demand ongoing clinical reasoning to balance the multi-faceted treatment approach. The patient's complex presentation requires regular reassessment of her cardiovascular status, renal function, and lipid profile to ensure that all therapeutic goals are met without introducing new adverse effects. This dynamic case emphasizes the importance of personalized medicine, as the care team continuously adapts the treatment regimen based on evolving clinical data and the patient's response to interventions, aiming to optimize her overall cardiovascular health.

Section 4

As the medical team continues to closely monitor the patient's cardiovascular status and response to treatment, a new set of laboratory results reveals an unexpected development. The patient's serum creatinine has risen to 1.5 mg/dL from a baseline of 1.0 mg/dL, and her blood urea nitrogen (BUN) is slightly elevated at 25 mg/dL. These findings suggest a potential decline in renal function, likely exacerbated by the initiation of the loop diuretic. Additionally, her potassium level has dropped to 3.2 mEq/L, raising concerns about hypokalemia, a known risk when using diuretics. Despite these changes, her blood pressure remains stable at 120/78 mmHg, and her peripheral edema has further decreased, indicating a partial success of the diuretic therapy.

These new lab results necessitate a careful reassessment of the patient's treatment plan. The healthcare team opts to adjust her medication regimen by introducing a potassium-sparing diuretic to counteract the hypokalemia while continuing to manage her fluid status. Furthermore, they decide to reduce the dosage of the loop diuretic to prevent further renal impairment. An in-depth discussion with the patient emphasizes the importance of monitoring her renal function and electrolytes closely, with plans for more frequent follow-up visits and laboratory tests to track her progress.

This change in the patient's status underscores the need for vigilant clinical reasoning and the delicate balancing act required in managing her complex condition. The team must weigh the benefits of effective blood pressure and edema control against the risks of renal compromise and electrolyte imbalance. This iterative process of reassessment and adjustment highlights the dynamic nature of personalized care, as the team strives to optimize the patient's cardiovascular and renal health while preventing further complications.

Section 5

Following the adjustment of the patient's medication regimen, the healthcare team closely monitors her response to the new treatment plan. During a follow-up visit, her laboratory results reveal that her serum potassium level has improved to 3.8 mEq/L, indicating a positive response to the introduction of the potassium-sparing diuretic. However, her serum creatinine has risen slightly to 1.6 mg/dL, and her BUN has increased to 28 mg/dL, suggesting that her renal function remains a concern despite the reduced dosage of the loop diuretic. Clinically, the patient reports feeling more fatigued than usual, and a physical examination reveals mild jugular venous distention and crackles at the lung bases, which raises suspicion for fluid overload.

These new findings prompt the healthcare team to conduct a comprehensive reassessment of the patient's overall fluid and electrolyte management. The patient is counseled on the importance of adhering to dietary modifications, including a low-sodium diet and adequate fluid intake, to help manage her condition. The team decides to implement a more aggressive monitoring strategy, including weekly lab tests and regular blood pressure checks, to ensure timely detection of any further renal deterioration or electrolyte imbalances. Additionally, they consider consulting a nephrologist to provide specialized input on managing her renal function and optimizing her cardiovascular health.

The persistence of renal function decline and emerging signs of fluid overload highlight the complex interplay between managing hypertension, fluid balance, and renal health. This situation requires ongoing clinical reasoning to balance the risks and benefits of each intervention. The team remains vigilant in their monitoring efforts, recognizing the need to potentially adjust the treatment plan further to prevent the progression of complications, while also preparing for the possibility of new interventions or referrals as the patient's journey continues.